Reduction of allogeneic transplant morbidity by combining peripheral blood and bone marrow progenitor cells

Leuk Lymphoma. 1993 Jul;10(4-5):405-6. doi: 10.3109/10428199309148568.

Abstract

One case has been reported of a patient undergoing allogeneic transplantation with peripheral blood progenitor cells (PBPCs) rather than bone marrow. We now report the first case of a patient who underwent an allogeneic transplant with bone marrow combined with PBPCs.

Publication types

  • Case Reports

MeSH terms

  • Amphotericin B / therapeutic use
  • Aspergillosis / complications
  • Aspergillosis / drug therapy
  • Blood Component Transfusion*
  • Bone Marrow Purging
  • Bone Marrow Transplantation / immunology
  • Bone Marrow Transplantation / methods*
  • Child
  • Colony-Stimulating Factors / therapeutic use
  • Combined Modality Therapy
  • Fatal Outcome
  • Female
  • Graft vs Host Disease / prevention & control
  • Hematopoietic Stem Cell Transplantation*
  • Hematopoietic Stem Cells*
  • Humans
  • Immunologic Factors / therapeutic use
  • Leukemia, Myeloid, Acute / therapy*
  • Lung Diseases, Fungal / complications
  • Recombinant Proteins / therapeutic use
  • Salvage Therapy
  • Transplantation, Homologous

Substances

  • Colony-Stimulating Factors
  • Immunologic Factors
  • Recombinant Proteins
  • Amphotericin B